Back to Results
First PageMeta Content
Gynaecological cancer / Ovarian cancer / Carcinoma


A preclinical profile of VB6-845: a recombinant immunotoxin for targeting ovarian cancer
Add to Reading List

Document Date: 2013-03-14 08:26:09

Open Document

File Size: 14,76 KB

Share Result on Facebook

City

Mississauga / Winnipeg / /

Company

Viventia Biotechnologies Inc. / /

MedicalCondition

ovarian cancer J. Browna / gynecological cancers / gynecological carcinomas / metastatic carcinomas / advanced disease / ovarian cancer / endometrial and cervical carcinomas / cancer / ON ABSTRACT Ovarian cancer / disease / epithelial carcinomas / /

MedicalTreatment

surgery / /

ProvinceOrState

Manitoba / /

SocialTag